MAPT and Alzheimer disease 3: Ultimately, synapses are considered the pathway for the spreading of tau pathology in AD3, hence a better understanding of how synapses and synaptic changes contribute to this process will be critical to develop targeted therapies for attenuating tau spreading to prevent downstream neurodegeneration and cognitive decline.